一品红(300723.SZ)：子公司获得复方聚乙二醇(3350)电解质散注册证书

Core Viewpoint - Yipinhong (300723.SZ) has received approval from the National Medical Products Administration for the drug registration certificate of Compound Polyethylene Glycol (3350) Electrolyte Powder, which is indicated for treating chronic constipation in children aged 1 to 11 years and fecal impaction in children aged 5 to 11 years [1] Group 1 - The approved drug is indicated for treating chronic constipation in children aged 1 to 11 years [1] - It is specifically used for treating fecal impaction, which is severe constipation accompanied by rectal and/or colonic fecal mass accumulation, in children aged 5 to 11 years [1] - The mechanism of action of Polyethylene Glycol 3350 is based on its osmotic effect in the intestines, with the onset of action varying depending on the severity of fecal impaction or chronic constipation [1] Group 2 - The electrolyte components of the drug are designed to maintain the balance of sodium, potassium, and water [1]